These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1516271)

  • 21. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
    Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardioprotective actions of potassium channel openers.
    Auchampach JA; Maruyama M; Gross GJ
    Eur Heart J; 1994 Aug; 15 Suppl C():89-94. PubMed ID: 7995278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KATP channels mediate adenosine-induced hyperemia in retina.
    Gidday JM; Maceren RG; Shah AR; Meier JA; Zhu Y
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2624-33. PubMed ID: 8977476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local cutaneous hemodynamic effects of carvedilol and labetalol in the anesthetized rat.
    Willette RN; Sauermelch CF; Ruffolo RR
    Eur J Pharmacol; 1990 Feb; 176(2):237-40. PubMed ID: 2311669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasodilator effects of cepharanthine, a biscoclaurine alkaloid, on cutaneous microcirculation in the rabbit.
    Asano M; Ohkubo C; Sasaki A; Sawanobori K; Nagano H
    J Ethnopharmacol; 1987 Jul; 20(2):107-20. PubMed ID: 3657244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats.
    Bowring NE; Arch JR; Buckle DR; Taylor JF
    Br J Pharmacol; 1993 Aug; 109(4):1133-9. PubMed ID: 8401925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats.
    Gardiner SM; Kemp PA; Bennett T
    Br J Pharmacol; 1991 Nov; 104(3):731-7. PubMed ID: 1797333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of BRL 38227, sodium nitroprusside and verapamil on collateral perfusion following acute arterial occlusion in the rabbit isolated ear.
    Randall MD; Griffith TM
    Br J Pharmacol; 1992 Jun; 106(2):315-23. PubMed ID: 1393264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats.
    Gardiner SM; Kemp PA; March JE; Fallgren B; Bennett T
    Br J Pharmacol; 1996 Feb; 117(3):507-515. PubMed ID: 8821541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo cardiac electrophysiologic effects of RWJ 29009, a new potassium-channel activator, in comparison to cromakalim and nicardipine.
    Damiano BP; Stump GL; Cheung WM; Salata JJ
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):143-52. PubMed ID: 7690086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
    Seki S; Sato K; Nakayama M; Murray PA
    Anesthesiology; 1997 Apr; 86(4):923-35. PubMed ID: 9105237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered cerebrovascular response to a potassium channel opener in hypertensive rats.
    Takaba H; Nagao T; Ibayashi S; Kitazono T; Fujii K; Fujishima M
    Hypertension; 1996 Jul; 28(1):143-6. PubMed ID: 8675255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGE1 improves blood flow in skin capillaries of conscious rats (WKY and SHR) through their lifetime in different dose ranges.
    Hertel RF; Creutzig A
    Prog Clin Biol Res; 1989; 301():429-33. PubMed ID: 2798456
    [No Abstract]   [Full Text] [Related]  

  • 35. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
    Auchampach JA; Grover GJ; Gross GJ
    Cardiovasc Res; 1992 Nov; 26(11):1054-62. PubMed ID: 1291082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
    Izumi H; Jinno Y; Kaneta S; Tanaka Y; Okada Y; Izawa T; Ogawa N
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):189-97. PubMed ID: 7475042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antihypertensive property of NIP-121, a novel potassium channel opener in rats.
    Masuda Y; Arakawa C; Yokoyama T; Shigenobu K; Tanaka S
    J Cardiovasc Pharmacol; 1991 Aug; 18(2):190-7. PubMed ID: 1717778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation.
    Randall MD; Ujiie H; Griffith TM
    Br J Pharmacol; 1994 May; 112(1):49-54. PubMed ID: 8032661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in myocardial infarct size by the new potassium channel opener bimakalim.
    Auchampach JA; Gross GJ
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):554-61. PubMed ID: 7516004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.